Valuation Neurizon Therapeutics Limited

Equities

Market Closed - Australian S.E. Other stock markets 11:14:53 12/05/2026 am IST			5-day change	1st Jan Change
0.0740 ^AUD	-2.63%		-8.64%	-12.94%

16/04	Neurizon Therapeutics Raises Nearly AU$3 Million to Reduce Entitlement Offer Shortfall; Shares Fall 7%	MT
16/04	Neurizon Therapeutics announces placement of entitlement offer shortfall to raise ~A$2.7 million	RE

Data adjusted to current consolidation scope

Fiscal Period: June	2020	2021	2022	2023	2024	2025
Capitalization ¹	46.81	28.82	22.18	26.06	86.78	78.77
Change	-	-38.43%	-23.03%	17.48%	232.99%	-9.23%
Enterprise Value (EV) ¹	45.4	27.08	21.15	24.39	76.05	74.59
Change	-	-40.36%	-21.89%	15.31%	211.83%	-1.92%
P/E ratio	-33.7x	-21.5x	-13x	-3.88x	-9.42x	-4.7x
PBR	5.49x	3.25x	2.83x	6.7x	8.48x	27.9x
PEG	-	2.71x	-0.5x	-0x	-1.36x	-0.1x
Capitalization / Revenue	11.4x	7.88x	4.92x	6.82x	103x	51.2x
EV / Revenue	11x	7.4x	4.69x	6.39x	90.4x	48.5x
EV / EBITDA	-41.5x	-24.4x	-14.6x	-7.91x	-13.1x	-4.4x
EV / EBIT	-36.4x	-21.3x	-13.1x	-7.5x	-13.1x	-4.4x
EV / FCF	-50.7x	-44x	-27.5x	-58x	-20.8x	-8.1x
FCF Yield	-1.97%	-2.27%	-3.63%	-1.72%	-4.8%	-12.4%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-0.0046	-0.004235	-0.00539	-0.0194	-0.0207	-0.034
Distribution rate	-	-	-	-	-	-
Net sales ¹	4.12	3.657	4.51	3.819	0.8417	1.538
EBITDA ¹	-1.094	-1.109	-1.453	-3.081	-5.815	-16.94
EBIT ¹	-1.247	-1.273	-1.62	-3.254	-5.817	-16.94
Net income ¹	-1.362	-1.337	-1.708	-6.212	-7.673	-16.59
Net Debt ¹	-1.413	-1.746	-1.035	-1.673	-10.73	-4.181
Reference price ²	0.1550	0.0910	0.0700	0.0750	0.1950	0.1600
Nbr of stocks (in thousands)	3,02,021	3,16,730	3,16,912	3,47,475	4,45,024	4,92,306
Announcement Date	18/09/20	18/08/21	26/08/22	31/08/23	30/08/24	25/08/25

¹AUD in Million²AUD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
NEURIZON THERAPEUTICS LIMITED	-	-	-	-	4.12Cr
ELI LILLY AND COMPANY	28.37x	10.33x	21.27x	0.7%	86TCr
JOHNSON & JOHNSON	23.66x	5.46x	14.85x	2.41%	53TCr
ABBVIE INC.	24.72x	6.13x	12.48x	3.38%	36TCr
ROCHE HOLDING AG	16.88x	4.23x	10.43x	3.14%	33TCr
ASTRAZENECA PLC	23.18x	4.81x	13.69x	1.8%	29TCr
NOVARTIS AG	20.19x	5.45x	13.25x	3.08%	28TCr
MERCK & CO., INC.	49.65x	4.63x	17.32x	2.99%	27TCr
NOVO NORDISK A/S	13.62x	4.97x	10.19x	3.72%	21TCr
AMGEN INC.	21.19x	5.8x	10.07x	3.06%	18TCr
Average	24.61x	5.76x	13.73x	2.7%	33.09TCr
Weighted average by Cap.	25.39x	6.54x	15.25x	2.31%